Arbutus Biopharma Corporation ABUS Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's total operating expenses?
- Arbutus Biopharma Corporation (ABUS) reported total operating expenses of $10.22M in Q1 2026.
- How has Arbutus Biopharma Corporation's total operating expenses changed year-over-year?
- Arbutus Biopharma Corporation's total operating expenses decreased by 62.8% year-over-year, from $27.46M to $10.22M.
- What is the long-term trend for Arbutus Biopharma Corporation's total operating expenses?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's total operating expenses has grown at a -11.3% compound annual growth rate (CAGR), from $84.51M to $52.24M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.